ArticlePloS one2025
Lantana camara plant extract catalyzed biosynthesis of graphene-metal nanocomposites with potential cytotoxic activities.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
- Commented on by
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the synthesis and characterization of Plant-Ag-graphene nanocomposites through a combination of spectroscopic and microscopic techniques, the nanocomposites were formed by catalyzing silver nanoparticles with plant extracts, and the resulting structures were analyzed using advanced instrumentation. In the FTIR analysis, distinctive peaks were observed at 3340 cm⁻1 (O-H stretching), 1740 cm⁻1 (C = O stretching), and 1050 cm⁻1. When compared to silver nanoparticles, the nanocomposites exhibited altered peak intensities, indicating modifications in chemical bonding. SEM images revealed that in nanocomposites, nanoparticles were adhered to graphene sheets, confirming the successful formation of Plant-Ag-graphene structures. EDX spectra showed a reduction in the silver content, confirming the integration of graphene into the nanocomposites. XRD analysis confirmed the presence of face-centered cubic-shaped Ag metal in the nanocomposites, while graphene exhibited a hexagonal crystalline shape. UV-Vis spectroscopy demonstrated shifts in peak positions, Spectrum A (400 to 700 nm) and spectrum B (265 nm), suggesting the successful synthesis of Plant-Ag-graphene nanocomposites. Moreover, the cytotoxic activity showed cell inhibition among Plant-Ag-Graphene (65.69%) and Plant-Ag (61.39%), respectively.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.